Biopharmaceutical Market Scope Rising With Escalating Health Concerns - IndustryARC
March 27, 2017 22:30 ET
|
IndustryARC
Hyderabad, India, March 27, 2017 (GLOBE NEWSWIRE) -- The report “Biopharmaceutical Market: By Source (Unicellular & Multicellular Systems) By Products (Vaccines, Enzymes, Others) Manufacturing...
FOURIER Trial Reveals Significant Reduction in Cardiovascular Risk
March 17, 2017 10:29 ET
|
National Lipid Association
WASHINGTON, DC--(Marketwired - March 17, 2017) - The FOURIER trial lead investigators announced today that the PCSK9 inhibitor evolocumab significantly reduced the risk of cardiovascular events by...
Johnson & Johnson and Big Pharma Could Find a Diabetes "Cure" With PharmaCyte Biotech's Type 1 Diabetes Treatment
February 08, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - February 08, 2016) - Johnson & Johnson (J&J), like much of the biopharmaceutical industry worldwide, is aware of the desperate necessity for a Type 1...
WeissLaw LLP Files a Class Action Lawsuit Challenging the Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. -- ONXX
August 30, 2013 14:54 ET
|
WeissLaw LLP
NEW YORK, Aug. 30, 2013 (GLOBE NEWSWIRE) -- WeissLaw LLP, a leading shareholder rights law firm, announces that it has filed a class action complaint in the Delaware Court of Chancery challenging the...
Former Amgen Executive Michael Petty Joins King & Spalding
July 11, 2012 09:00 ET
|
King & Spalding
WASHINGTON, DC--(Marketwire - Jul 11, 2012) - Michael D. Petty, the former vice president of development and regulatory law at Amgen Inc., has joined the FDA and life sciences practice of King...
Documents Uncovered by Judicial Watch Detail Big Pharma Campaign Access to Democratic Governors During 2012 National Governors Association Meeting
March 28, 2012 14:11 ET
|
Judicial Watch
WASHINGTON, DC--(Marketwire - Mar 28, 2012) - Judicial Watch, the public interest group that investigates and prosecutes government corruption, announced today that it has uncovered documents...
Binswanger and Kidder Mathews Named Exclusive Agent for Sublease of Class A Lab and Office Space in South San Francisco, California
February 07, 2012 13:55 ET
|
Binswanger
PHILADELPHIA, PA--(Marketwire - Feb 7, 2012) - Binswanger and Kidder Mathews have been named exclusive agents by Amgen, Inc. for the sublease of a two building Class A lab and office complex...